nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—MTNR1A—forebrain—attention deficit hyperactivity disorder	0.0378	0.241	CbGeAlD
Agomelatine—MTNR1A—nervous system—attention deficit hyperactivity disorder	0.0205	0.131	CbGeAlD
Agomelatine—MTNR1A—central nervous system—attention deficit hyperactivity disorder	0.0198	0.126	CbGeAlD
Agomelatine—MTNR1A—brain—attention deficit hyperactivity disorder	0.0157	0.1	CbGeAlD
Agomelatine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00926	0.0591	CbGeAlD
Agomelatine—HTR2B—forebrain—attention deficit hyperactivity disorder	0.0087	0.0555	CbGeAlD
Agomelatine—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.00735	0.047	CbGeAlD
Agomelatine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.00611	0.039	CbGeAlD
Agomelatine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.00503	0.0321	CbGeAlD
Agomelatine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.00484	0.0309	CbGeAlD
Agomelatine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00477	0.0304	CbGeAlD
Agomelatine—HTR2B—nervous system—attention deficit hyperactivity disorder	0.00472	0.0302	CbGeAlD
Agomelatine—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.00455	0.029	CbGeAlD
Agomelatine—HTR2C—brain—attention deficit hyperactivity disorder	0.00384	0.0245	CbGeAlD
Agomelatine—HTR2B—brain—attention deficit hyperactivity disorder	0.00361	0.023	CbGeAlD
Agomelatine—MTNR1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00229	0.00271	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00229	0.00271	CbGpPWpGaD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00226	0.00268	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00226	0.00268	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00226	0.00268	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00226	0.00268	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00223	0.00265	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00223	0.00265	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00219	0.0026	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00219	0.0026	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00215	0.00255	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00211	0.0025	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0021	0.0025	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0021	0.0025	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0021	0.00248	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00197	0.00233	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00197	0.00233	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00194	0.00229	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00194	0.00229	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00185	0.00219	CbGpPWpGaD
Agomelatine—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00181	0.00214	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00181	0.00214	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00174	0.00206	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0017	0.00202	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00169	0.002	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00167	0.00198	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00167	0.00198	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00154	0.00182	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00154	0.00182	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00152	0.0018	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00152	0.0018	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00149	0.00177	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00147	0.00175	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00147	0.00175	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00146	0.00173	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00146	0.00173	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00146	0.00173	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00146	0.00173	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00146	0.00173	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00146	0.00173	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00141	0.00167	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00138	0.00163	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00136	0.00161	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00136	0.00161	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00133	0.00157	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00133	0.00157	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00132	0.00157	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00132	0.00157	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00132	0.00156	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00132	0.00156	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00129	0.00153	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00129	0.00153	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00129	0.00153	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00129	0.00153	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00128	0.00152	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00128	0.00151	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00128	0.00151	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00127	0.0015	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00127	0.0015	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00125	0.00149	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00123	0.00146	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00123	0.00146	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00119	0.00142	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00119	0.00142	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00119	0.00141	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00119	0.00141	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00119	0.00141	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00118	0.0014	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00118	0.0014	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00117	0.00139	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00117	0.00139	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00116	0.00137	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00116	0.00137	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00115	0.00137	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00113	0.00134	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00113	0.00134	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00112	0.00133	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00111	0.00132	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0011	0.0013	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00108	0.00128	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00108	0.00128	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00108	0.00128	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00104	0.00123	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00103	0.00122	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00102	0.00121	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00101	0.0012	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000986	0.00117	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00097	0.00115	CbGpPWpGaD
Agomelatine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000959	0.00114	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000959	0.00114	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000958	0.00114	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000955	0.00113	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000955	0.00113	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000943	0.00112	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000929	0.0011	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000913	0.00108	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000902	0.00107	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000896	0.00106	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000896	0.00106	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000892	0.00106	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000884	0.00105	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000868	0.00103	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000844	0.001	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00084	0.000996	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000834	0.000989	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000833	0.000988	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000833	0.000988	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000822	0.000974	CbGpPWpGaD
Agomelatine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00082	0.000972	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000796	0.000944	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000794	0.000942	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000783	0.000929	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000783	0.000929	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000782	0.000928	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000778	0.000923	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000776	0.00092	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000773	0.000916	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00077	0.000913	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000761	0.000902	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000756	0.000897	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000756	0.000897	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000751	0.000891	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000749	0.000889	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000738	0.000875	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000729	0.000865	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000729	0.000865	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000728	0.000864	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000728	0.000864	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000721	0.000855	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00072	0.000853	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000707	0.000838	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000705	0.000836	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000705	0.000836	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000693	0.000822	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000693	0.000822	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000685	0.000812	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000685	0.000812	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000681	0.000807	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000679	0.000805	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000673	0.000798	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000641	0.00076	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000638	0.000756	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000638	0.000756	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000635	0.000753	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000628	0.000744	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000626	0.000742	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000625	0.000741	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000606	0.000719	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000596	0.000706	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000588	0.000698	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000588	0.000698	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000582	0.00069	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00057	0.000676	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000548	0.00065	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00054	0.00064	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00054	0.00064	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000539	0.00064	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000513	0.000608	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000513	0.000608	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000509	0.000604	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000506	0.0006	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000504	0.000598	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000496	0.000588	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00049	0.000581	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000476	0.000564	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000471	0.000559	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000447	0.00053	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000447	0.00053	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000438	0.00052	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000438	0.00052	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000435	0.000516	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000435	0.000516	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000432	0.000513	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000428	0.000508	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000426	0.000505	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000425	0.000503	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000417	0.000495	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000417	0.000495	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000412	0.000489	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000409	0.000485	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0004	0.000474	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000398	0.000472	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000395	0.000469	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000386	0.000457	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000384	0.000455	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000384	0.000455	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00038	0.000451	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000379	0.000449	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000374	0.000444	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000354	0.000419	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000349	0.000413	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000345	0.00041	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000344	0.000408	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000342	0.000406	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000337	0.000399	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000337	0.000399	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000332	0.000394	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00033	0.000392	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000321	0.000381	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000311	0.000369	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00031	0.000367	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000306	0.000362	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000302	0.000358	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000289	0.000343	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000281	0.000333	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000269	0.000319	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000253	0.0003	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000244	0.00029	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000237	0.000281	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000237	0.000281	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000235	0.000279	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000233	0.000277	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000228	0.00027	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000224	0.000265	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000221	0.000262	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000217	0.000257	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00021	0.000249	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000206	0.000244	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000204	0.000242	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000197	0.000234	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00019	0.000225	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000184	0.000218	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000181	0.000214	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000179	0.000213	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000178	0.000211	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000166	0.000197	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000145	0.000172	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000145	0.000172	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000144	0.000171	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000142	0.000169	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000132	0.000157	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000124	0.000147	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000124	0.000147	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000122	0.000144	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000116	0.000138	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000116	0.000137	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000113	0.000134	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00011	0.000131	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.89e-05	0.000117	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.42e-05	0.000112	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	8.77e-05	0.000104	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	8.71e-05	0.000103	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.45e-05	0.0001	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.64e-05	9.06e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	7.5e-05	8.89e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	7.45e-05	8.83e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.22e-05	8.56e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.17e-05	7.31e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	3.76e-05	4.46e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.22e-05	3.81e-05	CbGpPWpGaD
